ProclaimRx has launched a next-generation Marketing Mix Modeling (MMM) product
Read the press release here
ProclaimRx is excited to announce its launch of MMM product, which turns marketing mix modeling from a slow, once-a-year exercise into a living operating model, powered by its PLAiTO™ AI engine. With ProclaimRx MMM, commercial teams can run on-demand models using their most current data, simulate budget scenarios, and get real-time prescriptive recommendations to optimize ROI, with analyses that once took weeks now available in hours. Every recommendation traces directly back to the underlying data, analysis, and business assumptions, so marketing leaders can maximize their investments with confidence.
See how we are helping commercial teams make smarter investment decisions.
ProclaimRx is attending Reuters Pharma Customer Engagement USA this October 27-28!
Join us to see how we provide commercial, marketing, sales, and medical affair teams with decision-making workflows built for pharma.
We will be showcasing our new Marketing Investment workflow, which helps marketers understand what's driving performance, improve channel allocation, and make smarter investment decisions with advanced Marketing Mix Modeling (MMM).
Come meet the team at the exhibition hall or book a meeting with us.
ProclaimRx is headed to Fierce Pharma Week this September 14-17!
Come see how our AI data integration & intelligence platform transforms fragmented, chaotic commercial data streams into fast, trusted answers, so you can move beyond understanding what happened to controlling what happens next.
Come meet the team at Booth 420 or book a meeting with us.
The PM360 ELITE 100 recognizes the most influential people in healthcare and the life sciences—true catalysts who are creating extraordinary results. They are the industry's most powerful minds and are the ones responsible for designing the future of healthcare. They represent the top echelon of our industry based on the impact they have made throughout their careers.
ProclaimRx is proud to announce the following award winners from our leadership team:
See how PLAiTO™ is transforming the Commercial Intelligence process.
ProclaimRx will be participating in the "Startup Pitch Challenge" hosted by PM360, investors, and startup founders to feature the latest innovations disrupting healthcare and life sciences.
ProclaimRx is proud to be named one of just four companies nationwide selected for PM360’s 2025 Innovations in the Marketing Technology or Services category. This recognition reflects the impact our real‑time commercial intelligence platform is making in helping pharmaceutical teams move faster and make clearer decisions.
PM360’s selection highlights how our conversational AI and predictive modeling capabilities are turning complex, multi‑source data into actionable insight within seconds. We’re honored to be recognized for helping teams move from data to decisions in seconds.
ProclaimRx™ is an enterprise-grade AI platform that turns overwhelming pharma data into real-time, decision-ready intelligence—powered by the PLAiTO™ Intelligence Engine. It replaces months of manual analysis effort and equips teams to optimize investments, target customers, and analyze performance in minutes. Designed by industry veterans and technology pioneers in AI, ProclaimRx is redefining how commercial teams plan, execute, and optimize with speed and precision.
Join us and see how we are transforming the Commercial Intelligence process.
The pharmaceutical industry faces a challenging paradox: Commercial teams have more data about their markets than ever before, yet many struggle to turn this data into actionable information or make decisions as fast as markets demand. New tools, driven by advances in AI, ML and NLP, are empowering industry leaders to break free and transform their commercial intelligence process into a competitive advantage.
Through candid conversations with industry leaders, discover what it takes to successfully implement these new tools and generate meaningful operational benefits. We will explore how companies are compressing what once took months of fragmented analysis into confident strategic decisions in seconds.